Biotech entity

Dr. Azad Moopen

Person

Every one of those 1 sits in a single category, acquisition. Of the tracked stories, 1 of 1 also mention Aster DM Healthcare, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Dr. Azad Moopen, all published on March 13, 2026.

Last mentioned: Mar 13, 2026

Entity pulse

Recent coverage · Dr. Azad Moopen

1 story
6 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Dr. Azad Moopen

Every one of those 1 sits in a single category, acquisition. Of the tracked stories, 1 of 1 also mention Aster DM Healthcare, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Dr. Azad Moopen, all published on March 13, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Dr. Azad Moopen. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Shareholder Approval

    Overwhelming majority of shareholders and creditors vote in favor of the merger.

  2. Merger Agreement

    Aster DM India signs definitive merger agreement with Blackstone-backed QCIL.

  3. GCC Sale Completed

    Sale of Gulf assets to Alpha Gulf Health for $1.01 billion is finalized.

  4. Restructuring Announced

    Aster DM announces the separation of its GCC and India businesses.

Stories mentioning Dr. Azad Moopen 1

Acquisitions Strongly positive

Aster DM Healthcare Secures Overwhelming Approval for QCIL Merger

Aster DM Healthcare has cleared a major regulatory hurdle as shareholders and creditors overwhelmingly approved its merger with Quality Care India Limited (QCIL). The deal is set to create one of India’s largest hospital chains, significantly expanding Aster's domestic footprint following its strategic separation from its Gulf operations.

2 sources

Dr. Azad Moopen is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.